United States · FDA National Drug Code directory
INSULIN GLARGINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72572-422_83f8663d-cb21-9b78-e315-e0db15befb18
- Product NDC
- 72572-422
- Form
- INJECTION, SOLUTION
- Composition / generic term
- insulin glargine-yfgn
- Labeler
- Civica, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20251030
- Source listing expiry
- 20261231
Source-listed ingredients
- INSULIN GLARGINE — 100 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (72572-422-01) / 3 mL in 1 SYRINGE · 72572-422-01
- 5 SYRINGE in 1 CARTON (72572-422-05) / 3 mL in 1 SYRINGE · 72572-422-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →